In the present study, ssGSEA revealed that PD-1/PD-L1, TMB, and TILs were significantly different among LGG subtypes, highlighting the diversity of gliomas and providing new indicators for predicting ICB efficacy. This evidence concerns the gene CD274 and central nervous system cancer.